Clinical Trials Logo

Antiretroviral Side Effects clinical trials

View clinical trials related to Antiretroviral Side Effects.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01077765 Completed - HIV Infection Clinical Trials

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

LIPOPHILL
Start date: November 2005
Phase: Phase 3
Study type: Interventional

Combined antiretroviral therapy (cART) is associated with facial lipoatrophy, which is potentially stigmatizing for HIV-positive patients. Eutrophill is a 2.5% polyacrylamide hydrogel obtained by polymerization of acrylamide monomers with an official half-life of 5 years. Preliminary encouraging results with the use of polyacrylamide hydrogel for reconstruction of facial lipoatrophy in HIV-infected patients have been previously reported. The primary objective of the study was to evaluate the long-term efficacy and safety of subcutaneous facial injections of Eutrophill in HIV-infected patients with severe facial lipoatrophy as assessed by facial ultrasonography at screening , after 6, 12 and 24 months